Terms: = Cervical cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1 AND Treatment
20 results:
1. Combination treatment of Retinoic Acid Plus Focal Adhesion Kinase Inhibitor Prevents Tumor Growth and Breast cancer Cell Metastasis.
Castro-Guijarro AC; Vanderhoeven F; Mondaca JM; Redondo AL; Zoppino FCM; Fernandez-Muñoz JM; Sanchez AM; Flamini MI
Cells; 2022 Sep; 11(19):. PubMed ID: 36230951
[TBL] [Abstract] [Full Text] [Related]
2. Retinoic acid receptor-beta prevents cisplatin-induced proximal tubular cell death.
Yago-Ibáñez J; García-Pastor C; Lucio-Cazaña FJ; Fernández-Martínez AB
Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165795. PubMed ID: 32278009
[TBL] [Abstract] [Full Text] [Related]
3. Proliferation of cells and expression of rars, RXRs and HPV viral E6 and E7 proteins in cervical cancer cell lines after treatment with ATRA.
Myga-Nowak M; Pacholska-Bogalska J; Kwaśniewski W; Kwaśniewska A; Goździcka-Józefiak A
Ann Agric Environ Med; 2011; 18(1):145-50. PubMed ID: 21736279
[TBL] [Abstract] [Full Text] [Related]
4. rar-beta expression is associated with early volumetric changes to radiation therapy in cervical cancer.
Kim WY; Lee JW; Park YA; Choi JJ; Sung CO; Song SY; Choi CH; Kim TJ; Huh SJ; Kim BG; Bae DS
Gynecol Obstet Invest; 2011; 71(1):11-8. PubMed ID: 21160189
[TBL] [Abstract] [Full Text] [Related]
5. The cleavage fragment of retinoid X receptor-alpha ligand binding domain inhibits radiosensitization by retinoic acid.
Cho YM; Yang AH; Kim BY; Han YH
Oncol Rep; 2010 Jun; 23(6):1715-20. PubMed ID: 20428830
[TBL] [Abstract] [Full Text] [Related]
6. [Relationship between rar-beta gene expression defect and its methylation].
Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338
[TBL] [Abstract] [Full Text] [Related]
7. Sensitivity of human tumor cells to retinoids or combined treatment with retinoids and ionizing radiation is not dependent on rar-beta 2 induction.
Blaese MA; Santo-Hoeltje L; Rodemann HP
Strahlenther Onkol; 2003 Jun; 179(6):401-9. PubMed ID: 12789467
[TBL] [Abstract] [Full Text] [Related]
8. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy.
Segura-Pacheco B; Trejo-Becerril C; Perez-Cardenas E; Taja-Chayeb L; Mariscal I; Chavez A; Acuña C; Salazar AM; Lizano M; Dueñas-Gonzalez A
Clin Cancer Res; 2003 May; 9(5):1596-603. PubMed ID: 12738711
[TBL] [Abstract] [Full Text] [Related]
9. Activity of ALRT 1550, a new retinoid, with interferon-gamma on ovarian cancer cell lines.
Hu W; Verschraegen CF; Wu WG; Nash M; Freedman RS; Kudelka A; Kavanagh JJ
Int J Gynecol Cancer; 2002; 12(2):202-7. PubMed ID: 11975681
[TBL] [Abstract] [Full Text] [Related]
10. Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation.
Sah JF; Eckert RL; Chandraratna RA; Rorke EA
J Biol Chem; 2002 Mar; 277(12):9728-35. PubMed ID: 11788593
[TBL] [Abstract] [Full Text] [Related]
11. Related case report: in vivo suppression of thyrotropin by 9-cis retinoic acid.
Dabon-Almirante CL; Damle S; Wadler S; Hupart K
Cancer J Sci Am; 1999; 5(3):171-3. PubMed ID: 10367174
[TBL] [Abstract] [Full Text] [Related]
12. The effect of all-trans and 9-cis retinoic acid on the steady state level of HPV16 E6/E7 mRNA and cell cycle in cervical carcinoma cells.
Narayanan BA; Holladay EB; Nixon DW; Mauro CT
Life Sci; 1998; 63(7):565-73. PubMed ID: 9718082
[TBL] [Abstract] [Full Text] [Related]
13. Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide.
Sabichi AL; Hendricks DT; Bober MA; Birrer MJ
J Natl Cancer Inst; 1998 Apr; 90(8):597-605. PubMed ID: 9554442
[TBL] [Abstract] [Full Text] [Related]
14. Biological assay for activity and molecular mechanism of retinoids in cervical tumor cells.
Benbrook DM; Lu S; Flanagan C; Shen-Gunther J; Angros LH; Lightfoot SA
Gynecol Oncol; 1997 Jul; 66(1):114-21. PubMed ID: 9234931
[TBL] [Abstract] [Full Text] [Related]
15. The additive antiproliferative effect of all-trans retinoic acid and interferon-alpha2a on human cervical carcinoma cell lines is not associated with increased expression of retinoid receptors.
Wahlberg P; Einarsdottir M; Fex G; Rydell R
Anticancer Drugs; 1997 Jun; 8(5):522-8. PubMed ID: 9215617
[TBL] [Abstract] [Full Text] [Related]
16. Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells.
Zhang L; Nadzan AM; Heyman RA; Love DL; Mais DE; Croston G; Lamph WW; Boehm MF
J Med Chem; 1996 Jul; 39(14):2659-63. PubMed ID: 8709094
[TBL] [Abstract] [Full Text] [Related]
17. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
[TBL] [Abstract] [Full Text] [Related]
18. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract] [Full Text] [Related]
19. Detection of nuclear retinoic acid receptor mRNA in histological tissue sections using nonradioactive in situ hybridization histochemistry.
Xu XC; Clifford JL; Hong WK; Lotan R
Diagn Mol Pathol; 1994 Jun; 3(2):122-31. PubMed ID: 7520332
[TBL] [Abstract] [Full Text] [Related]
20. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells.
Bartsch D; Boye B; Baust C; zur Hausen H; Schwarz E
EMBO J; 1992 Jun; 11(6):2283-91. PubMed ID: 1318198
[TBL] [Abstract] [Full Text] [Related]
